ESMO Diagnosis, Treatment and Follow-up of Renal Cell Carcinoma Guideline Summary - Guideline Central

Document Overview

Document Title
Diagnosis, Treatment and Follow-up of Renal Cell Carcinoma
Authoring Society

European Society for Medical Oncology

Document Publication Date
May 22, 2024
Page Last Reviewed/Updated
May 5, 2026
Document Type
Guideline
Country of Publication
European
Full Text Freely Available
Yes
Full Text Guideline
www.annalsofoncology.org/article/S0923-7534(24)00676-8/fulltext
Source Citation

Powles T, Albiges L, Bex A, Comperat E, Grünwald V, Kanesvaran R, Kitamura H, McKay R, Porta C, Procopio G, Schmidinger M, Suarez C, Teoh J, de Velasco G, Young M, Gillessen S; ESMO Guidelines Committee. Electronic address: clinicalguidelines@esmo.org. Renal cell carcinoma: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up. Ann Oncol. 2024 Aug;35(8):692-706. doi: 10.1016/j.annonc.2024.05.537. Epub 2024 May 22. PMID: 38788900.

Document Scope, Criteria, and Use Cases

Document Objectives

Provide recommendations for managing renal cell carcinoma covering imaging and diagnosis, staging and risk assessment, treatment and follow-up. Algorithms for the management of localised and advanced or metastatic disease are also provided.

Scope
Diagnosis, Management, Treatment
Diseases/Conditions (MeSH)

D002292 - Carcinoma, Renal Cell

D002292 - Carcinoma, Renal Cell

Keywords
renal cell carcinoma (RCC)
Target Patient Population
Adults with renal cell carcinoma
Target Provider Population
Urologists, medical oncologists, surgical oncologists, radiation oncologists, pathologists, radiologists, nephrologists
Inclusion Criteria
Male, Female, Adult, Older Adult
Health Care Settings
Ambulatory, Hospital
Intended Users
Nurse, Nurse Practitioner, Physician, Physician Assistant
You rely on Guideline Central for transparency

Guideline Central and select third party use “cookies” on this website to enhance the user experience.

This technology helps us gather statistical and analytical information to optimize the relevant content for you.

The user also has the option to opt-out which may have an effect on the browsing experience.